TwinBeech Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-42,279
Closed -$420K 662
2025
Q3
$420K Sell
42,279
-214,385
-84% -$2.23M 0.02% 416
2025
Q2
$2.55M Buy
256,664
+195,523
+320% +$2.06M 0.06% 287
2025
Q1
$793K Sell
61,141
-1,602
-3% -$21.2K 0.01% 519
2024
Q4
$801K Sell
62,743
-6,540
-9% -$79.1K 0.01% 402
2024
Q3
$772K Sell
69,283
-103,014
-60% -$1.14M 0.01% 541
2024
Q2
$1.93M Sell
172,297
-11,068
-6% -$129K 0.04% 335
2024
Q1
$2.28M Sell
183,365
-42,928
-19% -$560K 0.05% 322
2023
Q4
$3.16M Buy
+226,293
New +$3.14M 0.05% 338
2023
Q1
Sell
-212,203
Closed -$2.26M 690
2022
Q4
$2.26M Buy
+212,203
New +$2.47M 0.04% 414

Other funds holding DVAX

TwinBeech Capital's DVAX Position: Q4 2025 in Review

TwinBeech Capital sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 42,279 shares — an estimated $420K sold.

TwinBeech Capital first reported a position in DVAX in Q4 2022 and held it in 9 quarters. The position peaked at $3.16M in Q4 2023. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • TwinBeech Capital reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • TwinBeech Capital sold 42,279 Dynavax Technologies shares in Q4 2025, an estimated $420K.
  • TwinBeech Capital first reported a position in Dynavax Technologies in Q4 2022 and held it in 9 quarters.
  • TwinBeech Capital's Dynavax Technologies position peaked at $3.16M in Q4 2023.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.